Grants and Contracts per year
Personal profile
Research Interests
Ovarian cancer; biomarkers; ovarian tumor diagnostics; ovarian ultrasound.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Residency, Univ Of Kentucky
1995
Doctor of Medicine, Bowman-Gray School Of Medicine
1990
Fingerprint
- 1 Similar Profiles
Network
-
State Matching: Kentucky Network for Innovation & Commercialization (#KYNETIC#) Yr 3
Dwoskin, L., Arnold, S., Bardo, M., Bondada, S., Fritz, M., Guy, R. K., Hall, E., Kolesar, J., McClure, I., Richards, C., Thorson, J., Ueland, F., Zhang, G., Abdel-Latif, A., Bruntz, R., Cassidy, R., Daugherty, A., Delisle, B., Feola, D., Gabr, M., Gensel, J., Gentry, M., Gordon, S., Hammill, J., Leggas, M., Lima, F., Lu, H., Malluche, H., Rao, M., Sheppard, M., Sun, R., Venditto, V., Zhan, C. & Zheng, F.
7/1/20 → 6/30/23
Project: Research project
-
CCSG Pilot: Pulse-dose Lapatinib Combined with Paclitaxel for the Treatment of Recurrent, Platinum-resistant Ovarian Cancer
Ueland, F., Evers, B. M., Kolesar, J., Wang, C. & Wu, J.
7/1/20 → 6/30/23
Project: Research project
-
GOG-3020/CO-338-087: ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy)
Gynecological Oncology Group Foundation Incorporated
11/30/18 → 12/18/23
Project: Research project
-
Human epidermal growth factor receptor 2 expression in women with uterine cervix adenocarcinoma from Appalachian Kentucky
Kunos, C. A., Fabian, D., Piecoro, D. W., Napier, D., Miller, R. W. & Ueland, F. R., Jan 24 2023, In: Frontiers in Oncology. 13, 948348.Research output: Contribution to journal › Article › peer-review
Open Access -
Human macrophage-engineered vesicles for utilization in ovarian cancer treatment
Schweer, D., Anand, N., Anderson, A., McCorkle, J. R., Neupane, K., Nail, A. N., Harvey, B., Hill, K. S., Ueland, F., Richards, C. & Kolesar, J., Jan 11 2023, In: Frontiers in Oncology. 12, 1042730.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies
Wei, Y., Erfani, S., Schweer, D., de Gouvea, R., Qadir, J., Shi, J., Cheng, K., Wu, D., Craven, R., Wu, Y., Olivier, T., Baldwin, L. A., Zhou, B., Zhou, Y., Zhao, W., Yang, B. B., Ueland, F. R. & Yang, X. H., Mar 16 2023, In: Molecular Therapy - Oncolytics. 28, p. 293-306 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)
Monk, B. J., Parkinson, C., Lim, M. C., O'malley, D. M., Oaknin, A., Wilson, M. K., Coleman, R. L., Lorusso, D., Bessette, P., Ghamande, S., Christopoulou, A., Provencher, D., Prendergast, E., Demirkiran, F., Mikheeva, O., Yeku, O., Chudecka-Glaz, A., Schenker, M., Littell, R. D., Safra, T., & 19 others , May 1 2022, In: Journal of Clinical Oncology. 381, JCO.22.01003.Research output: Contribution to journal › Article › peer-review
Open Access41 Scopus citations -
Factors Predicting Participation in the Prospective Genomic Sequencing Study, Total Cancer Care (TCC), in Kentucky
Riggs, M. J., Huang, B., Chen, Q., Bocklage, T., Schuh, M. R., Poi, M., Villano, J. L., Cavnar, M. J., Arnold, S. M., Miller, R. W., Ueland, F. R. & Kolesar, J. M., Jan 1 2022, In: Journal of Rural Health. 38, 1, p. 5-13 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations